Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma

« Previous Next »Cancer Treatment Reviews
Volume 35, Issue 8 , Pages 738-743, December 2009

Eirini Katodritou
- Department of Hematology, Theagenion Cancer Center, Thessaloniki, Greece
- Greek Myeloma Study Group, Greek Society of Hematology, Greece
Meletios A. Dimopoulos
- Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
- Greek Myeloma Study Group, Greek Society of Hematology, Greece
Konstantinos Zervas
- Department of Hematology, Theagenion Cancer Center, Thessaloniki, Greece
- Greek Myeloma Study Group, Greek Society of Hematology, Greece
Evangelos Terpos
- Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
- Greek Myeloma Study Group, Greek Society of Hematology, Greece
- Corresponding author. Addresses: Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital, Athens, Greece; 5 Marathonomahon street, 14572, Athens, Greece. Tel.: +30 210 7463803; fax: +30 210 7464676.